nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNH1—breast cancer	0.572	1	CbGaD
Dalfampridine—KCNH1—embryo—breast cancer	0.00274	0.0333	CbGeAlD
Dalfampridine—KCNS2—uterus—breast cancer	0.00217	0.0264	CbGeAlD
Dalfampridine—KCNF1—nipple—breast cancer	0.00211	0.0256	CbGeAlD
Dalfampridine—KCND1—embryo—breast cancer	0.00203	0.0247	CbGeAlD
Dalfampridine—KCNS2—female reproductive system—breast cancer	0.00196	0.0237	CbGeAlD
Dalfampridine—KCNB1—epithelium—breast cancer	0.00193	0.0235	CbGeAlD
Dalfampridine—KCNC3—epithelium—breast cancer	0.00188	0.0228	CbGeAlD
Dalfampridine—KCNS3—nipple—breast cancer	0.00185	0.0225	CbGeAlD
Dalfampridine—KCNC2—pituitary gland—breast cancer	0.00182	0.0221	CbGeAlD
Dalfampridine—KCNS1—epithelium—breast cancer	0.00174	0.0211	CbGeAlD
Dalfampridine—KCNG1—uterus—breast cancer	0.00165	0.02	CbGeAlD
Dalfampridine—KCNH3—pituitary gland—breast cancer	0.00162	0.0197	CbGeAlD
Dalfampridine—KCNH8—pituitary gland—breast cancer	0.00157	0.019	CbGeAlD
Dalfampridine—KCNA4—pituitary gland—breast cancer	0.00148	0.018	CbGeAlD
Dalfampridine—KCNS1—pituitary gland—breast cancer	0.00141	0.0171	CbGeAlD
Dalfampridine—KCNH1—endocrine gland—breast cancer	0.00141	0.0171	CbGeAlD
Dalfampridine—KCNH8—adrenal gland—breast cancer	0.0014	0.017	CbGeAlD
Dalfampridine—KCNC4—adipose tissue—breast cancer	0.00134	0.0163	CbGeAlD
Dalfampridine—KCNA3—adrenal gland—breast cancer	0.00132	0.0161	CbGeAlD
Dalfampridine—KCNA4—adrenal gland—breast cancer	0.00132	0.0161	CbGeAlD
Dalfampridine—KCNC1—pituitary gland—breast cancer	0.00129	0.0157	CbGeAlD
Dalfampridine—KCNF1—endometrium—breast cancer	0.00127	0.0155	CbGeAlD
Dalfampridine—KCNG1—endocrine gland—breast cancer	0.00125	0.0152	CbGeAlD
Dalfampridine—KCNS3—epithelium—breast cancer	0.00124	0.0151	CbGeAlD
Dalfampridine—KCND1—female reproductive system—breast cancer	0.00123	0.015	CbGeAlD
Dalfampridine—KCNB1—endocrine gland—breast cancer	0.00121	0.0147	CbGeAlD
Dalfampridine—KCNC4—adrenal gland—breast cancer	0.0012	0.0146	CbGeAlD
Dalfampridine—KCNS3—skin of body—breast cancer	0.00118	0.0144	CbGeAlD
Dalfampridine—KCNF1—pituitary gland—breast cancer	0.00115	0.014	CbGeAlD
Dalfampridine—KCNQ5—female reproductive system—breast cancer	0.00115	0.014	CbGeAlD
Dalfampridine—KCNF1—adipose tissue—breast cancer	0.00115	0.0139	CbGeAlD
Dalfampridine—KCNS3—endometrium—breast cancer	0.00112	0.0136	CbGeAlD
Dalfampridine—KCNA2—endocrine gland—breast cancer	0.00109	0.0132	CbGeAlD
Dalfampridine—KCND1—endocrine gland—breast cancer	0.00104	0.0127	CbGeAlD
Dalfampridine—KCNA5—pituitary gland—breast cancer	0.00103	0.0125	CbGeAlD
Dalfampridine—KCNS3—pituitary gland—breast cancer	0.00101	0.0123	CbGeAlD
Dalfampridine—KCNS3—adipose tissue—breast cancer	0.00101	0.0122	CbGeAlD
Dalfampridine—KCNA5—female reproductive system—breast cancer	0.000944	0.0115	CbGeAlD
Dalfampridine—KCNH6—uterus—breast cancer	0.000939	0.0114	CbGeAlD
Dalfampridine—KCNQ2—pituitary gland—breast cancer	0.00093	0.0113	CbGeAlD
Dalfampridine—KCNQ3—female reproductive system—breast cancer	0.000925	0.0112	CbGeAlD
Dalfampridine—KCNS3—adrenal gland—breast cancer	0.000902	0.011	CbGeAlD
Dalfampridine—KCNF1—endocrine gland—breast cancer	0.000893	0.0109	CbGeAlD
Dalfampridine—KCND2—pituitary gland—breast cancer	0.00088	0.0107	CbGeAlD
Dalfampridine—KCND2—adipose tissue—breast cancer	0.000877	0.0106	CbGeAlD
Dalfampridine—KCNA5—female gonad—breast cancer	0.000859	0.0104	CbGeAlD
Dalfampridine—KCNQ2—female reproductive system—breast cancer	0.000851	0.0103	CbGeAlD
Dalfampridine—KCNH6—female reproductive system—breast cancer	0.000844	0.0103	CbGeAlD
Dalfampridine—KCNA5—endocrine gland—breast cancer	0.000799	0.00971	CbGeAlD
Dalfampridine—KCNA3—lymph node—breast cancer	0.000793	0.00963	CbGeAlD
Dalfampridine—KCND3—uterus—breast cancer	0.000782	0.00949	CbGeAlD
Dalfampridine—KCNQ2—female gonad—breast cancer	0.000774	0.0094	CbGeAlD
Dalfampridine—KCND3—adipose tissue—breast cancer	0.000764	0.00928	CbGeAlD
Dalfampridine—KCNA2—lymph node—breast cancer	0.000754	0.00916	CbGeAlD
Dalfampridine—KCNQ1—pituitary gland—breast cancer	0.000743	0.00903	CbGeAlD
Dalfampridine—KCNQ1—adipose tissue—breast cancer	0.00074	0.00899	CbGeAlD
Dalfampridine—KCND2—female gonad—breast cancer	0.000733	0.00891	CbGeAlD
Dalfampridine—KCNC4—lymph node—breast cancer	0.000721	0.00876	CbGeAlD
Dalfampridine—KCNQ2—endocrine gland—breast cancer	0.00072	0.00875	CbGeAlD
Dalfampridine—KCND3—adrenal gland—breast cancer	0.000686	0.00833	CbGeAlD
Dalfampridine—KCNQ1—female reproductive system—breast cancer	0.00068	0.00826	CbGeAlD
Dalfampridine—KCNQ5—lymph node—breast cancer	0.000674	0.00819	CbGeAlD
Dalfampridine—KCNQ1—adrenal gland—breast cancer	0.000664	0.00806	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—breast cancer	0.000642	0.0078	CbGeAlD
Dalfampridine—KCNQ1—female gonad—breast cancer	0.000619	0.00752	CbGeAlD
Dalfampridine—KCNQ1—endocrine gland—breast cancer	0.000576	0.00699	CbGeAlD
Dalfampridine—KCNA5—lymph node—breast cancer	0.000552	0.00671	CbGeAlD
Dalfampridine—KCNS3—lymph node—breast cancer	0.000541	0.00657	CbGeAlD
Dalfampridine—KCNH2—nipple—breast cancer	0.000519	0.0063	CbGeAlD
Dalfampridine—KCND3—lymph node—breast cancer	0.000411	0.00499	CbGeAlD
Dalfampridine—KCNQ1—lymph node—breast cancer	0.000398	0.00483	CbGeAlD
Dalfampridine—KCNH2—endometrium—breast cancer	0.000313	0.0038	CbGeAlD
Dalfampridine—KCNH2—uterus—breast cancer	0.000289	0.0035	CbGeAlD
Dalfampridine—KCNH2—pituitary gland—breast cancer	0.000283	0.00344	CbGeAlD
Dalfampridine—KCNH2—female reproductive system—breast cancer	0.000259	0.00315	CbGeAlD
Dalfampridine—KCNH2—adrenal gland—breast cancer	0.000253	0.00307	CbGeAlD
Dalfampridine—KCNH2—bone marrow—breast cancer	0.000245	0.00297	CbGeAlD
Dalfampridine—KCNH2—female gonad—breast cancer	0.000236	0.00287	CbGeAlD
Dalfampridine—KCNH2—endocrine gland—breast cancer	0.000219	0.00267	CbGeAlD
Dalfampridine—CYP2E1—female reproductive system—breast cancer	0.0002	0.00243	CbGeAlD
Dalfampridine—CYP2E1—adrenal gland—breast cancer	0.000195	0.00237	CbGeAlD
Dalfampridine—CYP2E1—endocrine gland—breast cancer	0.000169	0.00205	CbGeAlD
Dalfampridine—Insomnia—Fluorouracil—breast cancer	0.000152	0.000912	CcSEcCtD
Dalfampridine—Convulsion—Paclitaxel—breast cancer	0.000152	0.000912	CcSEcCtD
Dalfampridine—KCNH2—lymph node—breast cancer	0.000152	0.00184	CbGeAlD
Dalfampridine—Gastrointestinal disorder—Irinotecan—breast cancer	0.000152	0.000909	CcSEcCtD
Dalfampridine—Vomiting—Goserelin—breast cancer	0.000151	0.000906	CcSEcCtD
Dalfampridine—Paraesthesia—Fluorouracil—breast cancer	0.000151	0.000906	CcSEcCtD
Dalfampridine—Constipation—Mitoxantrone—breast cancer	0.00015	0.0009	CcSEcCtD
Dalfampridine—Constipation—Irinotecan—breast cancer	0.00015	0.0009	CcSEcCtD
Dalfampridine—Angiopathy—Capecitabine—breast cancer	0.00015	0.0009	CcSEcCtD
Dalfampridine—Dyspnoea—Fluorouracil—breast cancer	0.00015	0.000899	CcSEcCtD
Dalfampridine—Rash—Goserelin—breast cancer	0.00015	0.000899	CcSEcCtD
Dalfampridine—Hypersensitivity—Thiotepa—breast cancer	0.00015	0.000898	CcSEcCtD
Dalfampridine—Dermatitis—Goserelin—breast cancer	0.00015	0.000898	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—breast cancer	0.00015	0.000898	CcSEcCtD
Dalfampridine—Immune system disorder—Capecitabine—breast cancer	0.00015	0.000896	CcSEcCtD
Dalfampridine—Chest pain—Paclitaxel—breast cancer	0.000149	0.000896	CcSEcCtD
Dalfampridine—Mediastinal disorder—Capecitabine—breast cancer	0.000149	0.000894	CcSEcCtD
Dalfampridine—Nasopharyngitis—Epirubicin—breast cancer	0.000149	0.000893	CcSEcCtD
Dalfampridine—Headache—Goserelin—breast cancer	0.000149	0.000893	CcSEcCtD
Dalfampridine—Anxiety—Paclitaxel—breast cancer	0.000149	0.000893	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	0.000148	0.00089	CcSEcCtD
Dalfampridine—Dyspepsia—Fluorouracil—breast cancer	0.000148	0.000888	CcSEcCtD
Dalfampridine—Nausea—Tamoxifen—breast cancer	0.000148	0.000887	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Gemcitabine—breast cancer	0.000148	0.000886	CcSEcCtD
Dalfampridine—Constipation—Gemcitabine—breast cancer	0.000146	0.000877	CcSEcCtD
Dalfampridine—Asthenia—Thiotepa—breast cancer	0.000146	0.000875	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Fluorouracil—breast cancer	0.000145	0.000871	CcSEcCtD
Dalfampridine—Mental disorder—Capecitabine—breast cancer	0.000145	0.000869	CcSEcCtD
Dalfampridine—Nausea—Melphalan—breast cancer	0.000145	0.000868	CcSEcCtD
Dalfampridine—Feeling abnormal—Mitoxantrone—breast cancer	0.000145	0.000868	CcSEcCtD
Dalfampridine—Feeling abnormal—Irinotecan—breast cancer	0.000145	0.000868	CcSEcCtD
Dalfampridine—Confusional state—Paclitaxel—breast cancer	0.000144	0.000866	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—breast cancer	0.000144	0.000863	CcSEcCtD
Dalfampridine—Anaphylactic shock—Paclitaxel—breast cancer	0.000143	0.000859	CcSEcCtD
Dalfampridine—Infection—Paclitaxel—breast cancer	0.000142	0.000853	CcSEcCtD
Dalfampridine—Nausea—Goserelin—breast cancer	0.000141	0.000847	CcSEcCtD
Dalfampridine—Feeling abnormal—Gemcitabine—breast cancer	0.000141	0.000845	CcSEcCtD
Dalfampridine—Dizziness—Vinorelbine—breast cancer	0.000141	0.000844	CcSEcCtD
Dalfampridine—Nervous system disorder—Paclitaxel—breast cancer	0.000141	0.000842	CcSEcCtD
Dalfampridine—Urticaria—Mitoxantrone—breast cancer	0.00014	0.000836	CcSEcCtD
Dalfampridine—Back pain—Capecitabine—breast cancer	0.000139	0.000835	CcSEcCtD
Dalfampridine—Skin disorder—Paclitaxel—breast cancer	0.000139	0.000834	CcSEcCtD
Dalfampridine—Feeling abnormal—Fluorouracil—breast cancer	0.000139	0.000831	CcSEcCtD
Dalfampridine—Nasopharyngitis—Doxorubicin—breast cancer	0.000138	0.000826	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—breast cancer	0.000137	0.000823	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—breast cancer	0.000137	0.000823	CcSEcCtD
Dalfampridine—Vomiting—Vinorelbine—breast cancer	0.000135	0.000812	CcSEcCtD
Dalfampridine—Tremor—Capecitabine—breast cancer	0.000135	0.000809	CcSEcCtD
Dalfampridine—Dizziness—Thiotepa—breast cancer	0.000135	0.000806	CcSEcCtD
Dalfampridine—Rash—Vinorelbine—breast cancer	0.000134	0.000805	CcSEcCtD
Dalfampridine—Dermatitis—Vinorelbine—breast cancer	0.000134	0.000804	CcSEcCtD
Dalfampridine—Hypotension—Paclitaxel—breast cancer	0.000134	0.000802	CcSEcCtD
Dalfampridine—Urticaria—Fluorouracil—breast cancer	0.000134	0.000801	CcSEcCtD
Dalfampridine—Headache—Vinorelbine—breast cancer	0.000133	0.0008	CcSEcCtD
Dalfampridine—Insomnia—Paclitaxel—breast cancer	0.00013	0.000777	CcSEcCtD
Dalfampridine—Hypersensitivity—Mitoxantrone—breast cancer	0.000129	0.000776	CcSEcCtD
Dalfampridine—Hypersensitivity—Irinotecan—breast cancer	0.000129	0.000776	CcSEcCtD
Dalfampridine—Vomiting—Thiotepa—breast cancer	0.000129	0.000775	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—breast cancer	0.000129	0.000773	CcSEcCtD
Dalfampridine—Paraesthesia—Paclitaxel—breast cancer	0.000129	0.000771	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—breast cancer	0.000128	0.00077	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—breast cancer	0.000128	0.00077	CcSEcCtD
Dalfampridine—Rash—Thiotepa—breast cancer	0.000128	0.000769	CcSEcCtD
Dalfampridine—Dermatitis—Thiotepa—breast cancer	0.000128	0.000768	CcSEcCtD
Dalfampridine—Dyspnoea—Paclitaxel—breast cancer	0.000128	0.000766	CcSEcCtD
Dalfampridine—Headache—Thiotepa—breast cancer	0.000127	0.000764	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—breast cancer	0.000127	0.000759	CcSEcCtD
Dalfampridine—Nausea—Vinorelbine—breast cancer	0.000127	0.000758	CcSEcCtD
Dalfampridine—Dyspepsia—Paclitaxel—breast cancer	0.000126	0.000756	CcSEcCtD
Dalfampridine—Asthenia—Mitoxantrone—breast cancer	0.000126	0.000755	CcSEcCtD
Dalfampridine—Asthenia—Irinotecan—breast cancer	0.000126	0.000755	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	0.000126	0.000754	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—breast cancer	0.000125	0.000748	CcSEcCtD
Dalfampridine—Hypersensitivity—Fluorouracil—breast cancer	0.000124	0.000743	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000124	0.000741	CcSEcCtD
Dalfampridine—Asthenia—Gemcitabine—breast cancer	0.000123	0.000736	CcSEcCtD
Dalfampridine—Chest pain—Capecitabine—breast cancer	0.000123	0.000735	CcSEcCtD
Dalfampridine—Constipation—Paclitaxel—breast cancer	0.000123	0.000734	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—breast cancer	0.000122	0.000734	CcSEcCtD
Dalfampridine—Anxiety—Capecitabine—breast cancer	0.000122	0.000733	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	0.000122	0.00073	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—breast cancer	0.000121	0.000728	CcSEcCtD
Dalfampridine—Nausea—Thiotepa—breast cancer	0.000121	0.000724	CcSEcCtD
Dalfampridine—Infection—Docetaxel—breast cancer	0.000121	0.000723	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—breast cancer	0.000119	0.000714	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—breast cancer	0.000119	0.000712	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—breast cancer	0.000119	0.000712	CcSEcCtD
Dalfampridine—Confusional state—Capecitabine—breast cancer	0.000119	0.000711	CcSEcCtD
Dalfampridine—Feeling abnormal—Paclitaxel—breast cancer	0.000118	0.000708	CcSEcCtD
Dalfampridine—Skin disorder—Docetaxel—breast cancer	0.000118	0.000707	CcSEcCtD
Dalfampridine—Infection—Capecitabine—breast cancer	0.000117	0.0007	CcSEcCtD
Dalfampridine—Dizziness—Irinotecan—breast cancer	0.000116	0.000696	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—breast cancer	0.000116	0.000692	CcSEcCtD
Dalfampridine—Nervous system disorder—Capecitabine—breast cancer	0.000115	0.000691	CcSEcCtD
Dalfampridine—Skin disorder—Capecitabine—breast cancer	0.000114	0.000685	CcSEcCtD
Dalfampridine—Urticaria—Paclitaxel—breast cancer	0.000114	0.000682	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—breast cancer	0.000114	0.00068	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—breast cancer	0.000113	0.000679	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—breast cancer	0.000112	0.00067	CcSEcCtD
Dalfampridine—Vomiting—Mitoxantrone—breast cancer	0.000112	0.000669	CcSEcCtD
Dalfampridine—Vomiting—Irinotecan—breast cancer	0.000112	0.000669	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—breast cancer	0.000111	0.000667	CcSEcCtD
Dalfampridine—Dizziness—Fluorouracil—breast cancer	0.000111	0.000667	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—breast cancer	0.000111	0.000665	CcSEcCtD
Dalfampridine—Rash—Irinotecan—breast cancer	0.000111	0.000664	CcSEcCtD
Dalfampridine—Rash—Mitoxantrone—breast cancer	0.000111	0.000664	CcSEcCtD
Dalfampridine—Dermatitis—Irinotecan—breast cancer	0.000111	0.000663	CcSEcCtD
Dalfampridine—Dermatitis—Mitoxantrone—breast cancer	0.000111	0.000663	CcSEcCtD
Dalfampridine—Headache—Mitoxantrone—breast cancer	0.00011	0.00066	CcSEcCtD
Dalfampridine—Headache—Irinotecan—breast cancer	0.00011	0.00066	CcSEcCtD
Dalfampridine—Hypotension—Capecitabine—breast cancer	0.00011	0.000659	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—breast cancer	0.00011	0.000658	CcSEcCtD
Dalfampridine—Paraesthesia—Docetaxel—breast cancer	0.000109	0.000654	CcSEcCtD
Dalfampridine—Vomiting—Gemcitabine—breast cancer	0.000109	0.000652	CcSEcCtD
Dalfampridine—Dyspnoea—Docetaxel—breast cancer	0.000108	0.000649	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—breast cancer	0.000108	0.000647	CcSEcCtD
Dalfampridine—Rash—Gemcitabine—breast cancer	0.000108	0.000647	CcSEcCtD
Dalfampridine—Dermatitis—Gemcitabine—breast cancer	0.000108	0.000646	CcSEcCtD
Dalfampridine—Headache—Gemcitabine—breast cancer	0.000107	0.000643	CcSEcCtD
Dalfampridine—Vomiting—Fluorouracil—breast cancer	0.000107	0.000641	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—breast cancer	0.000107	0.000641	CcSEcCtD
Dalfampridine—Insomnia—Capecitabine—breast cancer	0.000106	0.000637	CcSEcCtD
Dalfampridine—Rash—Fluorouracil—breast cancer	0.000106	0.000636	CcSEcCtD
Dalfampridine—Dermatitis—Fluorouracil—breast cancer	0.000106	0.000635	CcSEcCtD
Dalfampridine—Paraesthesia—Capecitabine—breast cancer	0.000106	0.000633	CcSEcCtD
Dalfampridine—Hypersensitivity—Paclitaxel—breast cancer	0.000106	0.000633	CcSEcCtD
Dalfampridine—Headache—Fluorouracil—breast cancer	0.000105	0.000632	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000105	0.000628	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—breast cancer	0.000105	0.000628	CcSEcCtD
Dalfampridine—Dyspnoea—Capecitabine—breast cancer	0.000105	0.000628	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—breast cancer	0.000105	0.000627	CcSEcCtD
Dalfampridine—Nausea—Irinotecan—breast cancer	0.000104	0.000625	CcSEcCtD
Dalfampridine—Nausea—Mitoxantrone—breast cancer	0.000104	0.000625	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—breast cancer	0.000104	0.000624	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—breast cancer	0.000104	0.000623	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—breast cancer	0.000104	0.000622	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—breast cancer	0.000104	0.000622	CcSEcCtD
Dalfampridine—Dyspepsia—Capecitabine—breast cancer	0.000104	0.00062	CcSEcCtD
Dalfampridine—Asthenia—Paclitaxel—breast cancer	0.000103	0.000616	CcSEcCtD
Dalfampridine—Nausea—Gemcitabine—breast cancer	0.000102	0.000609	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Capecitabine—breast cancer	0.000102	0.000608	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—breast cancer	0.000101	0.000605	CcSEcCtD
Dalfampridine—Constipation—Capecitabine—breast cancer	0.000101	0.000603	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—breast cancer	0.0001	0.0006	CcSEcCtD
Dalfampridine—Nausea—Fluorouracil—breast cancer	0.0001	0.000599	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—breast cancer	9.71e-05	0.000582	CcSEcCtD
Dalfampridine—Feeling abnormal—Capecitabine—breast cancer	9.69e-05	0.000581	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—breast cancer	9.68e-05	0.00058	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—breast cancer	9.64e-05	0.000578	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—breast cancer	9.62e-05	0.000576	CcSEcCtD
Dalfampridine—Dizziness—Paclitaxel—breast cancer	9.48e-05	0.000568	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—breast cancer	9.35e-05	0.00056	CcSEcCtD
Dalfampridine—Urticaria—Capecitabine—breast cancer	9.34e-05	0.00056	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—breast cancer	9.29e-05	0.000557	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—breast cancer	9.13e-05	0.000547	CcSEcCtD
Dalfampridine—Vomiting—Paclitaxel—breast cancer	9.11e-05	0.000546	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	9.07e-05	0.000543	CcSEcCtD
Dalfampridine—Rash—Paclitaxel—breast cancer	9.04e-05	0.000541	CcSEcCtD
Dalfampridine—Dermatitis—Paclitaxel—breast cancer	9.03e-05	0.000541	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—breast cancer	8.98e-05	0.000538	CcSEcCtD
Dalfampridine—Headache—Paclitaxel—breast cancer	8.98e-05	0.000538	CcSEcCtD
Dalfampridine—Hypersensitivity—Docetaxel—breast cancer	8.95e-05	0.000536	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—breast cancer	8.83e-05	0.000529	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—breast cancer	8.75e-05	0.000525	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—breast cancer	8.71e-05	0.000522	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—breast cancer	8.7e-05	0.000521	CcSEcCtD
Dalfampridine—Infection—Methotrexate—breast cancer	8.7e-05	0.000521	CcSEcCtD
Dalfampridine—Hypersensitivity—Capecitabine—breast cancer	8.66e-05	0.000519	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—breast cancer	8.59e-05	0.000514	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—breast cancer	8.55e-05	0.000512	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—breast cancer	8.52e-05	0.00051	CcSEcCtD
Dalfampridine—Nausea—Paclitaxel—breast cancer	8.51e-05	0.00051	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—breast cancer	8.5e-05	0.00051	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	8.49e-05	0.000509	CcSEcCtD
Dalfampridine—Asthenia—Capecitabine—breast cancer	8.44e-05	0.000506	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—breast cancer	8.26e-05	0.000495	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—breast cancer	8.19e-05	0.000491	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—breast cancer	8.18e-05	0.00049	CcSEcCtD
Dalfampridine—Infection—Epirubicin—breast cancer	8.14e-05	0.000488	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—breast cancer	8.05e-05	0.000482	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—breast cancer	8.03e-05	0.000481	CcSEcCtD
Dalfampridine—Dizziness—Docetaxel—breast cancer	8.03e-05	0.000481	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—breast cancer	7.96e-05	0.000477	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—breast cancer	7.92e-05	0.000474	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—breast cancer	7.91e-05	0.000474	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—breast cancer	7.88e-05	0.000472	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—breast cancer	7.86e-05	0.000471	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	7.85e-05	0.000471	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—breast cancer	7.81e-05	0.000468	CcSEcCtD
Dalfampridine—Dizziness—Capecitabine—breast cancer	7.78e-05	0.000466	CcSEcCtD
Dalfampridine—Vomiting—Docetaxel—breast cancer	7.72e-05	0.000463	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—breast cancer	7.71e-05	0.000462	CcSEcCtD
Dalfampridine—Rash—Docetaxel—breast cancer	7.66e-05	0.000459	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—breast cancer	7.66e-05	0.000459	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—breast cancer	7.65e-05	0.000459	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—breast cancer	7.64e-05	0.000458	CcSEcCtD
Dalfampridine—Headache—Docetaxel—breast cancer	7.61e-05	0.000456	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—breast cancer	7.58e-05	0.000454	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—breast cancer	7.56e-05	0.000453	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—breast cancer	7.53e-05	0.000451	CcSEcCtD
Dalfampridine—Vomiting—Capecitabine—breast cancer	7.48e-05	0.000448	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—breast cancer	7.43e-05	0.000445	CcSEcCtD
Dalfampridine—Rash—Capecitabine—breast cancer	7.42e-05	0.000444	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—breast cancer	7.41e-05	0.000444	CcSEcCtD
Dalfampridine—Dermatitis—Capecitabine—breast cancer	7.41e-05	0.000444	CcSEcCtD
Dalfampridine—Headache—Capecitabine—breast cancer	7.37e-05	0.000441	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—breast cancer	7.36e-05	0.000441	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—breast cancer	7.36e-05	0.000441	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—breast cancer	7.3e-05	0.000438	CcSEcCtD
Dalfampridine—Nausea—Docetaxel—breast cancer	7.21e-05	0.000432	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—breast cancer	7.21e-05	0.000432	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—breast cancer	7.21e-05	0.000432	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—breast cancer	7.08e-05	0.000424	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—breast cancer	7.07e-05	0.000424	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—breast cancer	7.01e-05	0.00042	CcSEcCtD
Dalfampridine—Nausea—Capecitabine—breast cancer	6.99e-05	0.000419	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—breast cancer	6.95e-05	0.000417	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—breast cancer	6.86e-05	0.000411	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—breast cancer	6.81e-05	0.000408	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—breast cancer	6.76e-05	0.000405	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—breast cancer	6.75e-05	0.000405	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—breast cancer	6.67e-05	0.0004	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—breast cancer	6.54e-05	0.000392	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—breast cancer	6.51e-05	0.00039	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—breast cancer	6.48e-05	0.000388	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—breast cancer	6.45e-05	0.000387	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—breast cancer	6.28e-05	0.000376	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—breast cancer	6.25e-05	0.000374	CcSEcCtD
Dalfampridine—Hypersensitivity—Epirubicin—breast cancer	6.04e-05	0.000362	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—breast cancer	6.02e-05	0.000361	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—breast cancer	5.88e-05	0.000352	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—breast cancer	5.79e-05	0.000347	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—breast cancer	5.59e-05	0.000335	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—breast cancer	5.57e-05	0.000334	CcSEcCtD
Dalfampridine—Rash—Methotrexate—breast cancer	5.52e-05	0.000331	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—breast cancer	5.51e-05	0.00033	CcSEcCtD
Dalfampridine—Headache—Methotrexate—breast cancer	5.48e-05	0.000329	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—breast cancer	5.44e-05	0.000326	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—breast cancer	5.42e-05	0.000325	CcSEcCtD
Dalfampridine—Vomiting—Epirubicin—breast cancer	5.21e-05	0.000312	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—breast cancer	5.2e-05	0.000312	CcSEcCtD
Dalfampridine—Rash—Epirubicin—breast cancer	5.17e-05	0.00031	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—breast cancer	5.16e-05	0.000309	CcSEcCtD
Dalfampridine—Headache—Epirubicin—breast cancer	5.13e-05	0.000308	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—breast cancer	5.01e-05	0.0003	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—breast cancer	4.87e-05	0.000292	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—breast cancer	4.82e-05	0.000289	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—breast cancer	4.78e-05	0.000286	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—breast cancer	4.78e-05	0.000286	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—breast cancer	4.75e-05	0.000285	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—breast cancer	4.5e-05	0.00027	CcSEcCtD
Dalfampridine—KCNC2—Metabolism—HMOX1—breast cancer	1.49e-05	8.32e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HMOX1—breast cancer	1.49e-05	8.32e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HMOX1—breast cancer	1.49e-05	8.32e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ITPR1—breast cancer	1.48e-05	8.3e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ITPR1—breast cancer	1.48e-05	8.3e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ITPR1—breast cancer	1.48e-05	8.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP3A4—breast cancer	1.48e-05	8.27e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—breast cancer	1.48e-05	8.27e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—breast cancer	1.48e-05	8.27e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—breast cancer	1.47e-05	8.25e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1B1—breast cancer	1.47e-05	8.24e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—breast cancer	1.47e-05	8.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1B1—breast cancer	1.45e-05	8.13e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—COMT—breast cancer	1.44e-05	8.04e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—breast cancer	1.43e-05	8.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—breast cancer	1.43e-05	8.03e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—breast cancer	1.43e-05	8e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—breast cancer	1.43e-05	8e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—breast cancer	1.43e-05	7.99e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—breast cancer	1.43e-05	7.99e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—breast cancer	1.43e-05	7.99e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—breast cancer	1.42e-05	7.94e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HMOX1—breast cancer	1.41e-05	7.89e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ITPR1—breast cancer	1.41e-05	7.87e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—NCOA1—breast cancer	1.4e-05	7.86e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMS—breast cancer	1.4e-05	7.85e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMS—breast cancer	1.4e-05	7.85e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMS—breast cancer	1.4e-05	7.85e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—breast cancer	1.4e-05	7.82e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—breast cancer	1.4e-05	7.82e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NCOR1—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NCOR1—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PLA2G4A—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PLA2G4A—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PLA2G4A—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NCOR1—breast cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP19A1—breast cancer	1.38e-05	7.75e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP19A1—breast cancer	1.37e-05	7.64e-05	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—breast cancer	1.36e-05	7.6e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—breast cancer	1.35e-05	7.57e-05	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—breast cancer	1.34e-05	7.49e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMS—breast cancer	1.33e-05	7.44e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPX1—breast cancer	1.33e-05	7.43e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPX1—breast cancer	1.33e-05	7.43e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPX1—breast cancer	1.33e-05	7.43e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—breast cancer	1.32e-05	7.4e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—breast cancer	1.32e-05	7.4e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NCOR1—breast cancer	1.31e-05	7.35e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—breast cancer	1.31e-05	7.35e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PLA2G4A—breast cancer	1.31e-05	7.35e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—breast cancer	1.31e-05	7.35e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—breast cancer	1.31e-05	7.35e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—breast cancer	1.31e-05	7.35e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAF1—breast cancer	1.31e-05	7.32e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAF1—breast cancer	1.31e-05	7.32e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ERCC2—breast cancer	1.3e-05	7.29e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ERCC2—breast cancer	1.3e-05	7.29e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ERCC2—breast cancer	1.3e-05	7.29e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RELA—breast cancer	1.3e-05	7.29e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RELA—breast cancer	1.3e-05	7.29e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—breast cancer	1.29e-05	7.24e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—breast cancer	1.29e-05	7.24e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—COMT—breast cancer	1.29e-05	7.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—breast cancer	1.28e-05	7.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—COMT—breast cancer	1.27e-05	7.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—breast cancer	1.26e-05	7.07e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPX1—breast cancer	1.26e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—breast cancer	1.26e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—breast cancer	1.26e-05	7.04e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—breast cancer	1.25e-05	6.99e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—breast cancer	1.25e-05	6.97e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ERCC2—breast cancer	1.23e-05	6.91e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—breast cancer	1.23e-05	6.9e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—breast cancer	1.22e-05	6.85e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—breast cancer	1.22e-05	6.85e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—breast cancer	1.22e-05	6.85e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—breast cancer	1.19e-05	6.65e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—breast cancer	1.19e-05	6.65e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—breast cancer	1.18e-05	6.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—breast cancer	1.16e-05	6.5e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—breast cancer	1.16e-05	6.5e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—breast cancer	1.14e-05	6.37e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—breast cancer	1.14e-05	6.37e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—breast cancer	1.13e-05	6.34e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—breast cancer	1.13e-05	6.34e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAV1—breast cancer	1.13e-05	6.32e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAV1—breast cancer	1.13e-05	6.32e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAV1—breast cancer	1.13e-05	6.32e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—breast cancer	1.12e-05	6.25e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—breast cancer	1.11e-05	6.21e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—breast cancer	1.11e-05	6.21e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—breast cancer	1.1e-05	6.16e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAV1—breast cancer	1.07e-05	5.99e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—breast cancer	1.07e-05	5.99e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—breast cancer	1.03e-05	5.78e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—RAF1—breast cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—breast cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—breast cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—breast cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—breast cancer	1.02e-05	5.73e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—breast cancer	1.02e-05	5.73e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—breast cancer	1.01e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—breast cancer	1.01e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—breast cancer	9.97e-06	5.58e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—breast cancer	9.97e-06	5.58e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—breast cancer	9.87e-06	5.52e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—breast cancer	9.87e-06	5.52e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—breast cancer	9.75e-06	5.46e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—breast cancer	9.66e-06	5.41e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—breast cancer	9.66e-06	5.41e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—breast cancer	9.43e-06	5.28e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—breast cancer	9.43e-06	5.28e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—breast cancer	9.15e-06	5.12e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—breast cancer	9.15e-06	5.12e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—breast cancer	9.04e-06	5.06e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—breast cancer	9.04e-06	5.06e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—breast cancer	9.04e-06	5.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SYNJ2—breast cancer	8.98e-06	5.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—breast cancer	8.97e-06	5.02e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—breast cancer	8.97e-06	5.02e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—breast cancer	8.93e-06	5e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—breast cancer	8.93e-06	5e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—breast cancer	8.93e-06	5e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—breast cancer	8.63e-06	4.83e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—breast cancer	8.57e-06	4.8e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—breast cancer	8.54e-06	4.78e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—breast cancer	8.54e-06	4.78e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NOS3—breast cancer	8.54e-06	4.78e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NOS3—breast cancer	8.54e-06	4.78e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NOS3—breast cancer	8.54e-06	4.78e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—breast cancer	8.47e-06	4.74e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—breast cancer	8.47e-06	4.74e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—breast cancer	8.46e-06	4.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFS3—breast cancer	8.35e-06	4.67e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NOS3—breast cancer	8.1e-06	4.53e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—breast cancer	7.88e-06	4.41e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—breast cancer	7.88e-06	4.41e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—breast cancer	7.88e-06	4.41e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CHST9—breast cancer	7.85e-06	4.39e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—breast cancer	7.81e-06	4.37e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—breast cancer	7.81e-06	4.37e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—breast cancer	7.81e-06	4.37e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—breast cancer	7.47e-06	4.18e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COX11—breast cancer	7.44e-06	4.16e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—breast cancer	7.4e-06	4.14e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—breast cancer	7.2e-06	4.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—breast cancer	7.2e-06	4.03e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—breast cancer	6.89e-06	3.86e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—breast cancer	6.89e-06	3.86e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—breast cancer	6.81e-06	3.81e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—breast cancer	6.81e-06	3.81e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—breast cancer	6.81e-06	3.81e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CDA—breast cancer	6.8e-06	3.81e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SHMT1—breast cancer	6.8e-06	3.81e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A5—breast cancer	6.55e-06	3.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLCO1B1—breast cancer	6.55e-06	3.67e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—breast cancer	6.46e-06	3.61e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—breast cancer	6.36e-06	3.56e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—breast cancer	6.36e-06	3.56e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APRT—breast cancer	6.32e-06	3.54e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ESRRA—breast cancer	5.95e-06	3.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ANGPTL4—breast cancer	5.95e-06	3.33e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—breast cancer	5.67e-06	3.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HADHB—breast cancer	5.64e-06	3.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPI—breast cancer	5.64e-06	3.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH7A1—breast cancer	5.38e-06	3.01e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDH1A1—breast cancer	5.38e-06	3.01e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADSL—breast cancer	5.16e-06	2.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NME1—breast cancer	5.16e-06	2.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FHL2—breast cancer	5.16e-06	2.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PHGDH—breast cancer	5.16e-06	2.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UMPS—breast cancer	5.16e-06	2.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—LDHB—breast cancer	5.06e-06	2.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BRIP1—breast cancer	5.06e-06	2.83e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPSE—breast cancer	5.06e-06	2.83e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—breast cancer	4.81e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—breast cancer	4.81e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—breast cancer	4.81e-06	2.69e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCC1—breast cancer	4.79e-06	2.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMMR—breast cancer	4.79e-06	2.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA3—breast cancer	4.79e-06	2.68e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPARGC1B—breast cancer	4.64e-06	2.6e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—breast cancer	4.56e-06	2.55e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA9—breast cancer	4.38e-06	2.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA4—breast cancer	4.38e-06	2.45e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA2—breast cancer	4.27e-06	2.39e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX2—breast cancer	4.27e-06	2.39e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SULT1A1—breast cancer	4.22e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX4—breast cancer	4.22e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—IDH1—breast cancer	4.12e-06	2.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA1—breast cancer	4.12e-06	2.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NAT2—breast cancer	4.08e-06	2.28e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—breast cancer	3.93e-06	2.2e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—breast cancer	3.93e-06	2.2e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—breast cancer	3.93e-06	2.2e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—breast cancer	3.72e-06	2.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DPYD—breast cancer	3.57e-06	2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MED12—breast cancer	3.57e-06	2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDOA—breast cancer	3.52e-06	1.97e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA3—breast cancer	3.42e-06	1.91e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A2—breast cancer	3.39e-06	1.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CPT1A—breast cancer	3.32e-06	1.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTR—breast cancer	3.32e-06	1.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG2—breast cancer	3.32e-06	1.86e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPGDS—breast cancer	3.26e-06	1.82e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HBA1—breast cancer	3.24e-06	1.81e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—breast cancer	3.16e-06	1.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACHE—breast cancer	3.16e-06	1.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP17A1—breast cancer	2.99e-06	1.67e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS1—breast cancer	2.96e-06	1.66e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO1—breast cancer	2.96e-06	1.66e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2D6—breast cancer	2.9e-06	1.63e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA2—breast cancer	2.85e-06	1.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FASN—breast cancer	2.76e-06	1.55e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—breast cancer	2.75e-06	1.54e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC5A5—breast cancer	2.72e-06	1.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NQO1—breast cancer	2.63e-06	1.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC2A1—breast cancer	2.63e-06	1.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP3A4—breast cancer	2.56e-06	1.43e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1B1—breast cancer	2.52e-06	1.41e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSP90AA1—breast cancer	2.47e-06	1.38e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA1—breast cancer	2.4e-06	1.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP19A1—breast cancer	2.37e-06	1.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STK11—breast cancer	2.37e-06	1.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COMT—breast cancer	2.2e-06	1.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—breast cancer	2.19e-06	1.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMOX1—breast cancer	2.16e-06	1.21e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ITPR1—breast cancer	2.16e-06	1.21e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—breast cancer	2.07e-06	1.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMS—breast cancer	2.04e-06	1.14e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLA2G4A—breast cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOR1—breast cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—breast cancer	2.01e-06	1.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPX1—breast cancer	1.93e-06	1.08e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—breast cancer	1.91e-06	1.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ERCC2—breast cancer	1.89e-06	1.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—breast cancer	1.78e-06	9.96e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAV1—breast cancer	1.64e-06	9.19e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—breast cancer	1.49e-06	8.37e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—breast cancer	1.31e-06	7.36e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—breast cancer	1.3e-06	7.26e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NOS3—breast cancer	1.24e-06	6.95e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.15e-06	6.41e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—breast cancer	1.13e-06	6.35e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—breast cancer	9.9e-07	5.54e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—breast cancer	6.98e-07	3.91e-06	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—breast cancer	5.7e-07	3.19e-06	CbGpPWpGaD
